| Mepha Pharma AG - Gliclazid-Mepha Teva MR 30 mg, Retardtabletten |
| 65694 | | 01 | | Gliclazid-Mepha Teva MR 30 mg | | Retardtabletten | | A10BB09 | | Gliclazide | | 17.09.2015 | | |
|
| Composition |
| gliclazidum 30 mg, lactosum monohydricum 56.8 mg, hypromellosum, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Delayed release tablets | | | | Active Agent | Dose |
|---|
| Gliclazide | 30 mg |
| | | | Inactive agents | Dose |
|---|
| Cellulosum Microcristallinum | | | Hypromellosum | | | Lactose Monohydrate | 56.8 mg | | Magnesii Stearas | | | Pro Compresso | | | Silica Colloidalis Anhydrica | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | 30 | | | B | | Yes | | 007 | 120 | | | B | | Yes |
|
